Transcranial Magnetic Stimulation for Evaluation and Treatment of Repetetive Behaviors in Autism
Repetetive Transcranial Magnetic Stimulation for Evaluation and Treatment of Repetetive Behavior in Subjects With Autism Spectrum Disorders.
Sponsor: New York State Psychiatric Institute
Terminated
Principal investigator (Dr. Sporn) left the sponsoring institution.
Other terminated trials from New York State Psychiatric Institute
- Opioid Overdose · Phase PHASE2 · Oct 2024
- Cognitive Change · Phase NA · Jun 2024
- HIV Prevention · Phase NA · Apr 2023
- Cigarette Smoking · Phase NA · Dec 2022
- Chronic Pain · Phase NA · Aug 2022
See all terminations from New York State Psychiatric Institute
Other Asperger Disorder trials with similar outcome
This PHASE2 trial investigates Asperger Disorder and Autism and is currently terminated or withdrawn. New York State Psychiatric Institute leads this study, which shows 6 recorded versions since 2008 — indicating limited longitudinal coverage. This study adds to the longitudinal dataset for psychiatric treatment development.
Status Flow
Change History
6 versions recorded-
Sep 2024 — Present [monthly]
Terminated PHASE2
-
Jul 2024 — Sep 2024 [monthly]
Terminated PHASE2
-
Jan 2021 — Jul 2024 [monthly]
Terminated PHASE2
-
Jun 2018 — Jan 2021 [monthly]
Terminated PHASE2
-
May 2017 — Jun 2018 [monthly]
Terminated PHASE2
▶ Show 1 earlier version
-
Jan 2017 — May 2017 [monthly]
Terminated PHASE2
First recorded
Nov 2008
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- New York State Psychiatric Institute
For direct contact, visit the study record on ClinicalTrials.gov .